Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial

Subjects

Subjects :

Hepatology
Gastroenterology

Details

ISSN :

24681253

Volume :

8

Database :

OpenAIRE

Journal :

The Lancet Gastroenterology & Hepatology

Accession number :

edsair.doi...........3004b349f7a78fc05a63ecaec0f6df4e

Full Text :

https://doi.org/10.1016/s2468-1253(23)00010-9